Mucus-Controlling Drug Therapy
29 Questions
11 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary purpose of using mucoactive agents in respiratory therapy?

  • To strengthen lung tissue
  • To enhance lung capacity
  • To reduce accumulation of airway secretions (correct)
  • To increase mucus production
  • Which of the following diseases is NOT associated with the use of mucolytics?

  • Bronchiectasis
  • Cystic fibrosis
  • Chronic bronchitis
  • Type 2 diabetes (correct)
  • What is one characteristic function of mucus in the respiratory system?

  • To prevent lung inflation
  • To reduce oxygen absorption
  • To trap harmful gases
  • To lubricate the airways (correct)
  • N-Acetylcysteine (NAC) is commonly known as which of the following?

    <p>Mucomyst</p> Signup and view all the answers

    Which type of solution is NOT classified as an aqueous aerosol for mucus management?

    <p>Isotonic Sodium Bicarbonate</p> Signup and view all the answers

    When should mucoactive agents be considered for therapy?

    <p>After removing irritants like tobacco smoke</p> Signup and view all the answers

    What is a common misconception about the mucociliary escalator?

    <p>It prevents infections solely on its own.</p> Signup and view all the answers

    How much mucus does a normal person produce in a 24-hour period?

    <p>100 mL</p> Signup and view all the answers

    What is the primary role of a mucokinetic agent?

    <p>To enhance cough or ciliary clearance</p> Signup and view all the answers

    Which of the following is NOT a factor that slows mucociliary transport rate?

    <p>Regular physical exercise</p> Signup and view all the answers

    What condition is most effectively treated by mucoregulatory agents?

    <p>Bronchorrhea</p> Signup and view all the answers

    Which agent would increase the viscosity of respiratory secretions?

    <p>Mucospissic agent</p> Signup and view all the answers

    How does cigarette smoke impact mucociliary transport?

    <p>It may increase transport at low concentrations</p> Signup and view all the answers

    What is the relationship between food intake and mucus production?

    <p>There is no association with dairy products and respiratory symptoms</p> Signup and view all the answers

    Which respiratory condition is characterized by the presence of plastic bronchitis?

    <p>Cystic fibrosis</p> Signup and view all the answers

    What effect do atmospheric pollutants have on mucociliary transport at higher concentrations?

    <p>They decrease transport rates</p> Signup and view all the answers

    What is the primary mode of action of N-Acetyl-L-cysteine (NAC)?

    <p>It disrupts the structure of mucus by breaking disulfide bonds.</p> Signup and view all the answers

    Which of the following adverse effects is associated with Dornase Alfa (Pulmozyme)?

    <p>Significant voice alteration</p> Signup and view all the answers

    For what primary condition is Dornase Alfa typically indicated?

    <p>Cystic fibrosis</p> Signup and view all the answers

    What is the common belief about the action of iodide-containing agents like SSKI?

    <p>They stimulate secretion of airway fluid.</p> Signup and view all the answers

    What is a significant hazard associated with the use of N-Acetyl-L-cysteine (NAC)?

    <p>Mechanical obstruction of airway</p> Signup and view all the answers

    What mechanism is attributed to the ineffectiveness of sodium bicarbonate as an expectorant?

    <p>Absence of clinical evidence for improved mucus clearance.</p> Signup and view all the answers

    In terms of mucokinetic agents, which of the following descriptions is accurate?

    <p>They increase cough clearance by increasing expiratory airflow.</p> Signup and view all the answers

    Which mucoactive therapy is primarily recommended for patients with neurological muscular weakness?

    <p>Insufflation-Exsufflation</p> Signup and view all the answers

    What is a key property of Guaifenesin as an expectorant?

    <p>It stimulates the gastrointestinal tract to aid in mucus expectoration.</p> Signup and view all the answers

    Which type of medication can aid in decreasing mucus hypersecretion?

    <p>Steroids and anticholinergics</p> Signup and view all the answers

    What is a common side effect of Dornase Alfa that is comparable to a placebo?

    <p>Voice alteration</p> Signup and view all the answers

    Which class of mucoregulatory medications is known to include Atropine?

    <p>Anticholinergics</p> Signup and view all the answers

    Which delivery method is NOT used for administering Dornase Alfa?

    <p>Intravenous injection</p> Signup and view all the answers

    Study Notes

    Mucus-Controlling Drug Therapy

    • Mucociliary escalator is the major defense system of the respiratory tract
    • Failure of the mucociliary escalator can result in mechanical obstruction of the airway, known as mucus plugging
    • Mucus plays a crucial role in the body, acting as a protective, lubricating, and waterproofing agent
    • Mucus also entraps microorganisms, further supporting its protective function

    Clinical Indications for Use

    • Reducing airway secretions is crucial for improving pulmonary function, gas exchange, preventing infections, and minimizing airway damage
    • Diseases that benefit from mucus-controlling therapy include cystic fibrosis, chronic bronchitis, pneumonia, diffuse panbronchiolitis, primary ciliary dyskinesia, asthma, and bronchiectasis
    • Therapy to decrease infection and inflammation, along with removing irritants like tobacco smoke, can contribute to improved mucus control

    Identification of Agents

    • N-Acetylcysteine (NAC) is also known as Mucomyst
    • Dornase alfa is commercially available as Pulmozyme
    • Aqueous aerosols, including sterile water, hypotonic saline, isotonic saline, and hyperosmolar saline (3% and 7%), are commonly used for mucus control

    Mucus Statistics

    • A healthy individual typically produces around 100 mL of mucus per day
    • Most of the mucus is reabsorbed by the bronchial mucosa
    • Roughly 10 mL reaches the glottis and is predominantly swallowed

    Mucociliary System

    • The mucociliary system consists of cilia, mucus, and glands
    • Cilia exhibit rhythmic beating patterns to propel mucus upwards
    • Cilia are found in both large and smaller airways with variations in size

    Factors Impacting Mucociliary Transport

    • Conditions like chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) can impair mucociliary transport
    • Airway drying, narcotics, and suctioning can also hinder mucociliary transport
    • Airway trauma, tracheostomy, cigarette smoke, and certain atmospheric pollutants can adversely affect mucociliary transport
    • Hyperoxia and hypoxia can also impact mucociliary transport
    • Food intake, particularly dairy products, has not been linked to respiratory symptom presentation with congestion or nasal secretion weight

    Mucus in Disease States

    • Excessive mucus accumulation is a hallmark of various respiratory diseases
    • These diseases include chronic bronchitis, asthma, bronchorrhea, plastic bronchitis, and cystic fibrosis

    Mucoactive Agents

    • Mucolytic agents reduce the elasticity and viscosity of mucus by breaking down its gel structure
    • Therapeutic approaches to manage hypersecretion involve removing causative factors, optimizing tracheobronchial clearance, and utilizing mucoactive agents when necessary
    • Classic mucolytics break down mucins by severing disulfide bonds

    N-Acetyl-L-cysteine (NAC)

    • N-Acetyl-L-cysteine (NAC) is indicated for treating conditions associated with viscous secretions, including acetaminophen overdose
    • NAC disrupts mucus structure by breaking disulfide bonds connecting mucin proteins

    Hazards of N-Acetyl-L-cysteine (NAC)

    • Bronchospasm can occur, but is less common with the 10% solution
    • Mechanical obstruction of the airway is a possible hazard
    • Incompatibilities with antibiotics in mixtures exist
    • Specific incompatible antibiotics include sodium ampicillin, amphotericin B, erythromycin lactobionate, tetracyclines, and aminoglycosides

    Dornase Alfa (Pulmozyme)

    • Dornase alfa is specifically indicated for cystic fibrosis patients
    • It helps clear purulent secretions and reduces the frequency of respiratory infections requiring antibiotic treatment
    • Dornase alfa aims to improve or preserve pulmonary function in patients with cystic fibrosis

    Dornase Alfa (Pulmozyme) Mode of Action

    • Dornase alfa reduces mucus viscosity and adhesivity by breaking down DNA, particularly when delivered via aerosol

    Dornase Alfa (Pulmozyme) Dose Administration

    • Dornase alfa is available in single-use ampules (2.5 mg drug in 2.5 mL solution)
    • It requires refrigeration and protection from light
    • The typical dose is 2.5 mg daily, delivered using a nebulizer
    • Approved nebulizers include Hudson RCI UP-DRAFT II OPTI-NEB, Acorn II, and PARI LC PLUS

    Dornase Alfa (Pulmozyme) Adverse Effects

    • Dornase alfa has minimal adverse effects compared to placebo
    • Common side effects include voice alteration, pharyngitis, laryngitis, rash, chest pain, and conjunctivitis

    Expectorants

    • Iodide-containing agents like supersaturated potassium iodide (SSKI) are generally considered expectorants
    • They are believed to stimulate airway fluid secretion
    • Sodium bicarbonate may draw water into secretions due to its inflammatory properties
    • There is no clinical evidence to support the efficacy of sodium bicarbonate for airway mucus clearance
    • Its use for chlorine inhalation may be beneficial
    • Guaifenesin is commonly considered an expectorant
    • However, it can be ciliotoxic when applied directly to respiratory epithelium
    • Its expectorant action is thought to occur through GI tract stimulation

    Mucokinetic Agents

    • Mucokinetic agents increase cough clearance by enhancing expiratory airflow or reducing sputum adhesivity and tenacity
    • Bronchodilators can increase ciliary beat, however, it has minimal impact on mucus clearance
    • Bronchodilators may increase mucus production

    Mucoregulatory Medications

    • Mucoregulatory medications aim to decrease mucus hypersecretion
    • Medications in this category include steroids, anticholinergics (Atropine, Ipratropium bromide, Tiotropium), and macrolide antibiotics
    • Specific macrolide antibiotics include Biaxin and Zithromax

    Other Mucoactive Agents

    • Antiproteases play a role in mucus control
    • α1-Antitrypsin can be administered intravenously or through inhalation

    Chest Physiotherapy

    • Physical therapies, such as chest physiotherapy, help mobilize and clear airway secretions

    Using Mucoactive Therapy with Physiotherapy and Airway Clearance Devices

    • Insufflation-Exsufflation (Cough Assist) uses positive and negative pressures to simulate a cough
    • This technique is particularly useful for patients with neurological or muscular weakness
    • High-frequency techniques, such as high-frequency chest wall compression (HFCWC), demonstrate effectiveness in enhancing secretion clearance
    • Techniques like Flutter Valve, PEP Therapy, EzPAP, Chestvest, and Meta Neb assist in mobilizing and clearing secretions
    • Exercise also plays a role in airway clearance

    Conclusion

    • Mucoactive agents provide a crucial therapeutic approach for conditions characterized by excessive mucus accumulation
    • These agents, in combination with physiotherapy and airway clearance devices, contribute to effective mucus management, enhancing respiratory function
    • Selecting the appropriate agent and therapy regimen depends on the underlying condition and individual patient needs

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    Explore the essential principles of mucus-controlling drug therapy and its vital role in respiratory health. Understand the clinical indications for usage, including conditions like cystic fibrosis and asthma, and learn about agents like N-Acetylcysteine. This quiz covers crucial concepts in pulmonary function and airway management.

    More Like This

    Use Quizgecko on...
    Browser
    Browser